Canaccord Genuity Starts BioNTech (BNTX) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
BofA/Merrill Lynch Starts BioNTech (BNTX) at Buy
November 4, 2019 6:15 AM ESTBofA/Merrill Lynch initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.91 yesterday.
... MoreUBS Starts BioNTech (BNTX) at Buy
November 4, 2019 4:27 AM ESTUBS analyst Andrew Ang initiates coverage on BioNTech (NASDAQ: BNTX) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.52 yesterday.
... MoreJPMorgan Starts BioNTech (BNTX) at Overweight
November 4, 2019 2:30 AM ESTJPMorgan analyst Cory Kasimov initiates coverage on BioNTech (NASDAQ: BNTX) with a Overweight rating and a price target of $23.00.
For an analyst ratings summary and ratings history on BioNTech click here. For more ratings news on BioNTech click here.
Shares of BioNTech closed at $16.52 yesterday.
... More


